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Selected factors have been evaluated in order to determine their influences on the plasma
lipoprotein proton NMR spectra ofnormal and cancerpatients. Thevariables were donor's diet
(fasting/non-fasting), temperature and time ofsample storage, processing procedure, centrifu-
gation speed, and water pre-saturation time. Plasma samples from fasting individuals that were
placed immediately on ice, spun at 1,000 and 3,000 g for 15 minutes, and the proton NMR
spectrum acquired with the Carr-Purcell Meiboom-Gill (CPMG) pulse sequence, using a
two-second water pre-saturation time, consistently gave reproducible results. Resonances
attributed to lactate were minimized under these processing conditions. Centrifugation speed
and pre-saturation time did not affect the average line width; however, donor fasting state,
processing temperature, and storage time did alter the line width. Most important, blood
chemistry analysis revealed an inverse correlation between triglyceride levels and average
methyl and methylene line widths. Thus, these factors alone caution against the indiscriminate
use ofproton NMR spectra to differentiate plasma from normal and cancer patients.
INTRODUCTION
An easy, accurate, and non-invasive test for screening early malignancy has long
been sought in vain. Fossel et al. reported that the average line widths of plasma
lipoprotein lipid methyl and methylene resonances in water-suppressed proton
nuclearmagnetic resonance (NMR) spectrawere narrower incancerpatientsthan in
healthy controls [1]. They initially reported that the mean line width for 44 normal
controls was 39.5 + 1.6 Hz, while that of81 untreated cancer patients was 29.2 + 2.5
Hz with no overlap (p < 0.0001) [1]. Thus a line width of 33 Hz was set as a line of
demarcation in detecting cancer.
This use ofhigh-resolution proton NMR spectra ofplasma as a means ofdetecting
malignancy has been received with guarded optimism. The cause of the line width
narrowing phenomenon was not elucidated, although Fossel et al. postulated that
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the decreased line widths observed in cancer patients may be due to the increased
transverse relaxation (T2) time of these lipid resonances as a result of an undefined
host response reflected in an increased lipoprotein lipid mobility. Since line width
and transverse relaxation time are inversely related, increased lipid mobility would
thus give rise to narrow linewidths. Subsequently, Otvos et al. reported that the ratio
of intensities (RI) ofthe lipoprotein lipid methyl resonance calculated from spectra
acquired with short (2.4 msec) and long (120 msec) variable delay (T) in the
Carr-Purcell Meiboom-Gill (CGMG) pulse sequence is a more sensitive means of
differentiating between narrow and broad linewidth groups [2].
In related earlier studies, Mountford et al. noted high levels of triglycerides and
cholesterol esters in the plasma membranes of a metastatic rat mammary adenocar-
cinoma cell line [3]. They suggested that these high levels could be responsible for
the observed long T2 values. In low-density lipoproteins (LDLs), phase transition
temperatures decrease as the triglyceride/cholesterol ester ratio increases [4]. A
change inphase to a lessordered statewouldthusresult in increased lipid mobility in
LDLs, thereby producing narrower linewidths. In subsequent studies, Mountford et
al. also reported the presence of a distinct proteolipid (lipoprotein) complex
containing a 20 percent glycolipid component (fucogangliosides) in the plasma of a
patientwith malignancy [5].
These studies have generated much interest and skepticism as to thevalidityofthe
so-called "Fossel" test. Many groups who repeated Fossel's protocol have found
unacceptable overlap of line width measurements between cancer and normal
patients [6-12]. Such inability to reproduce Fossel's results could have been due to
the possibility that manyvariableswere not identically controlled, compared to those
of the Fossel protocol, and the result has raised important questions regarding the
reproducibility and validity of proton NMR of plasma as a means of distinguishing
malignancy from normal state.
It seemed clear, therefore, that inorder tocompare databetween laboratories and
to optimize the sensitivity of such measurements, the variables affecting proton
NMR linewidthneeded tobe identified andcontrolled. In ourstudy,we investigated
the effects of several factors which may affect such measurements. These were
sample handlingtime, sample handlingtemperature, probe temperature, centrifuga-
tion speed, water pre-saturation time, and patient dietary status (fasting or non-
fasting). We also analyzed various plasma lipid components of cancer and healthy
controls, to understand better the underlying biochemical basis for the line width
narrowing phenomenon.
MATERIALS AND METHODS
Subjects
Plasma samples were obtained from eight patients with metastatic malignancies,
including carcinoma of the colon, stomach, and breast, diffuse non-Hodgkin's
lymphoma, and liposarcoma. All patients were undergoing chemotherapy. Nine
normal samples were obtained from apparently healthy male and female volunteers
ranging in age from 23 to 53 years. One normal subject was subsequently diagnosed
ashavingbenign prostatic hypertrophy (BPH), a condition reported to affect average
line width [1].
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Sample Collection
Plasma samples forthe dietarystudywereobtained from a normal (BPH) donor in
the fasting state, and 30, 60, and 120minutes postprandially. Plasma samples from all
normal donors not in the dietary study were taken after a 12-hour fast. The dietary
status ofthe cancer patientswas not controlled, and the sampleswere obtained in an
outpatient clinic.
SamplePreparation
Blood plasma samples was collected in ethylenediamine tetraacetate (EDTA)
Vacutainers (Becton Dickinson). Except for changes in the variable under study, all
specimens were handled by the following procedure: samples were placed on ice
immediately upon collection and all subsequent processing was done in a cold room
at 4°C. Samples were first centrifuged in their collection tubes at 1,000 g for 15
minutes; plasma supernatant was transferred to a new Vacutainer and again centri-
fuged at3,000gfor 15 minutes. Followingthecentrifugation, 0.4mlofplasma and0.1
mlofdeuteriumoxide (D20) wereplaced in5 mmNMRtubesand stored at4°Cuntil
proton NMR spectra were recorded. Times from collection until spin were typically
less than one hour. Effects of temperature were studied by preparing samples as
above, at room temperature (27°C) and in a cold room (4°C).
Plasma Chemistry
Some of the components of the plasma lipoprotein were determined, using an
EPOS Analyzer 5060 (EM Diagnostics) with the following diagnostic reagent kits:
Fastchem cholesterol (Boehringer-Mannheim Diagnostics), HDL-cholesterol No.
351 (Sigma Diagnostics), and Triglyceride No. 338 (Sigma Diagnostics). Total
protein was determined on a Gemini centrifugal analyzer, using a Gemini Biuret
Reagent kit (ElectroNucleonics, Inc.).
NMR Spectroscopy
High-resolution 1H NMR measurements were performed on a Bruker AM 500
MHz (11.7 T) spectrometer. All measurements were made on spinning 0.5 ml
samples in5 mmtubes at25°CwithD20 as aninternallock. Spectra at500 MHzwere
acquired with eight transients preceded by four dummy scans, using the CPMG
method with 8 K data points and an acquisition time of 0.95 second. Variable (T)
delays used in the CPMG sequence were 3.2, 12, 100, and 120 msec. The water
pre-saturation pulse time was two seconds, except in a study ofthisvariable. All free
induction decays (FIDs) were processedwith a 1 Hz linebroadening. Linewidths for
the plasma lipoprotein lipid methyl and methylene resonances at 0.9 ppm and 1.3
ppm, respectively, were calculated at halfthe distance from the baseline to the apex
of the peak in a manner similar to the procedure used by Fossel et al. (Fig. 1). The
optimal phasing ofthese spectra was achieved by setting the phase correction in any
particular CPMG data set equal to that determined for the longest (T) delay where
the broad underlying background signal is absent. The spectra used to calculate the
ratio of intensities (RI) data for the plasma lipoprotein lipid methyl peaks were
collected with eithervariable (T) delays of3.2 and 120 msec, as reported by Otvos et
al. [2], or 12 and 100 msec for the earlier runs in the CPMG pulse sequence.
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Temperature-dependent NMR studies were performed on a Bruker MSL 200 MHz
(4.7 T) spectrometer at temperatures ranging from 10-45°C.
StatisticalMethods
The significance ofdifferences in meanswas calculated bythe t test, and the linear
correlation oftwovariables, r, bythe Pearson product-moment formula.
RESULTS
The mean average linewidth observed for the nine normal controlswas 41.0 + 7.0
Hz (range, 27.9-51.7 Hz) while that of the eight treated cancer patients was 35.2 +
5.5 Hz (range, 24.1 - 42.5 Hz). The mean methyl RI of the control group was
5.22 + 2.37 (range, 1.66-8.96) while that ofthe cancer groupwas 2.10 + 0.90 (range,
0.66-3.64)(Fig. 2). For the average line width measurements, there was a consider-
able overlap between the cancer and normal groups, and the differences between
control and cancer group means were not significant (p > 0.3). For the ratio of
intensities measurements, the difference between the means was significant
(p < 0.005), even though the range of values had some overlap. In comparison,
Fossel et al. reported that the mean line width for 44 normal controls was 39.5 + 1.6
Hz, while that ofthe 81 untreated cancer patientswas 29.2 ± 2.5 Hzwith no overlap
(p <0.0001) [1].
The effect of diet (fasting versus non-fasting) on the plasma lipid line widths and
RI was studied by obtaining blood samples from one fasting normal donor, one-half,
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one, and two hours after a high-fat meal. As anticipated, plasma samples obtained
postprandially showed increased lipid resonance intensities when compared with
those ofthe same donor in the fasting state. There were nochanges in the methyl RI,
but a small decrease (3.6-2.9 Hz) in the average linewidthwas notedbetweenfasting
and postprandial samples (Fig. 3).
The effect ofvarying centrifugation speed was studied at 1,000, 2,000, 3,000, 5,000,
and 10,000 g to establish whether high-speed spins may separate out some plasma
components such as fibrin, a process which may change the line width or RI results.
No significant changes in the average line widths (maximum variation, +2.1 Hz) or
RI (maximumvariation, +0.29) were noted, however, in several combinations ofspin
speeds tested (Fig. 4).
The effect ofsample storage time at 40C was studied on three control samples for
19 days because reproducibility of data was important for samples which were
allowed to stand for prolonged periods of time in storage. Our study showed that
there was no change in the average line width up to 19 days of storage; however, it
was interesting to note that the RI increased as a function oftime exceptfor one time
point in one sample (Fig. 5). Samples stored beyond 19 days were not studied. We
observed that some samples which were stored for several days had white precipi-
tates at the bottom ofthe NMR tubes. Furthermore, plasma samples stored at room
temperature for over 24 hours showed a large increase in lactate methyl doublet at
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1.35 ppm (J = 7.35 Hz) whereas samples stored at 4°C showed minimal increase in
the lactate doublet (Fig. 1).
The effect ofvariouswater pre-saturation times on the average line widths and RI
were studied because Fossel et al. [1] used insix-secondpre-saturation time,whereas
the protocol prepared by G.N. Chmurny at NIH [personal communication] recom-
mended a two-second pre-saturation time. Three random plasma samples (two
cancer, onecontrol)were analyzed atpre-saturation times of0.5, 1.5,2.0, 4.0, and 5.0
seconds. Over this range ofpre-saturation times, no significant changes in line width
or RI were observed (Fig. 6).
The effect of varying NMR probe temperatures on the plasma line width was
studied on two normal samples, since increasing sample temperatures may increase
the mobility of methyl and methylene groups of the lipids of lipoproteins, thus
causing a decrease in the lipid proton line width. This studywas done on a 200 MHz
NMR spectrometer, acquiring data at temperatures rangingfrom 10-45°C. Asample
with low triglyceride level of42 mg/dl showed a sigmoidal change in the average line'H NMR STUDY OF HUMAN PLASMA LIPOPROTEINS
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width when plotted as a function oftemperatures (Fig. 7, sample A). The part ofthe
curve with highest slope (temperature, 15-25°C) probably indicates the phase
transition of cholesterol ester in the plasma lipoproteins from solid to liquid phase,
since liquid phase has increased methyl and methylene mobility, resulting in lower
lipid line width. On the contrary, sample B, with a relatively high triglyceride level of
129 mg/dl, exhibited no significant line width changes; the average line widths were
nearly constant at 16-17 Hz over the temperature range examined. Such an observa-
tion is most likely due to a decreased phase transition temperature of the lipid
lipoproteins with high triglyceride levels [13]. This sample may have been in a liquid
phase at temperatures above 10°C, thus resulting in almost constant average line
width at higher temperatures.
Finally, the effect of various plasma lipoprotein components on the average line
width was studied by comparing the plasma levels of cholesterol, high-density
lipoprotein (HDL) cholesterol, triglycerides, and total protein with the average line
width. We assumed that, of the many components of plasma, the substances which
are most likely to affect the proton NMR spectra of the plasma lipids were the
individual plasma lipid components and the total plasma proteins. The latter might
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be expected to exert a concentration-dependent effect in its role as the principal
determinant of plasma viscosity. Five available normal and eight cancer patients
were studied. The comparisons revealed a significant linear inverse correlation
betweenplasmatriglyceride level andthelipid linewidth (Fig. 8, r = -.59,p < 0.05).
Other plasma components showed no significant correlations.
DISCUSSION
We have investigated various experimental and technical factors which can affect
the proton NMR spectra of plasma lipids and tried to elucidate the biochemical
mechanism behind Fossel's line width narrowing phenomenon. Such a study was
necessary in order to compare data among independent researchers and to enhance
reproducibility. Among the factors that were tested, triglycerides in plasma had the
most significant line width narrowing property, creating "Fossel-positive" results.
Such a finding was not surprising since Deckelbaum et al. [4,13] had shown that
triglycerides in LDL can interact with cholesterol esters and lower phase transition
temperature ofplasma lipids.'H NMR STUDY OF HUMAN PLASMA LIPOPROTEINS
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Since the completion of our investigation, others have also shown that a positive
Fossel test is secondary to a hyperlipidemic condition [15-18,22,23], and that a
completeseparation ofmalignant (linewidth < 33 Hz) from normal(linewidth > 33
Hz) state is not reproducible [7,10-12,14,15,24-26]. Thorough studies done by
Wilding et al. [15] and most recentlybyChmurny et al. [27] demonstrated, however, a
consistent pattern of a lower mean average line width for cancer patients compared
to healthy controls. We believe that this significantly lower average line width in
cancer patients may be due to the production of tumor necrosis factr in the host
response to malignant tumor, which can suppress lipoprotein lipase and result in
elevated triglyceride levels inplasma. The exactbiochemical mechanism ofthis effect
oftumor necrosis factor is still not fully understood and deserves further study.
In this study, the average line width measurements exhibited mean values that
were not significantly different between cancer and normal patients, in contrast to
those reported by Fossel et al. Furthermore, there was extensive overlap in the
ranges ofthese values for the two groups, causing the results for anygiven individual
to be of minimal diagnostic importance. The ratio of intensities measurements did,
however, show a significant difference between the group means but with some
71LIM ET AL.
TEMP (C)
40 -
SAMPLE B
30 -
20 -
10
O-0 10 20 30 40 50 6(
TEMP (C)
11-1
tQ
F-
04
z
0.4
04
FIG. 7. Average line widths of
plasma lipoprotein lipids at various
NMRprobetemperatures. A.Nor-
mal plasma sample with a low tri-
glyceride level (42 mg/dl) showing a
heating andcoolingcycle; B. nor-
mal plasma sample with a higher tri-
glyceride level (129 mg/dl).
overlap. Several other laboratories also reported significant overlap in the values of
line width measurements between cancer and control groups [7,10-12,14,15]. It
should be noted that all cancer patients in our study were concurrently undergoing
chemotherapy. Even though Fossel studied only patients with untreated malignant
tumors, Wilding et al. reported that there were no significant differences in average
line width measurements between treated and untreated populations [15]. Further-
more, there were no apparent differences among the line width measurements in
three patients onwhomboth pre-treatment and follow-up sampleswere obtained.
We observed that some sample processing variables had no effect on line width
and RI measurements. Centrifugation speed (1,000 to 10,OOOg) did not appear tobe
of any importance as long as the samples were spun at low speed initially to prevent
hemolysis. Similarly, there were no changes in the proton NMR spectra of plasma
samples accumulated with varying water pre-saturation times of 0.5 to 5.0 seconds.
We followed the protocol prepared by G.N Chmurny at NIH [personal communica-
tion] because two-second water pre-saturation time can adequately suppress the
water proton signal while avoiding problems associated with sample heating and
possible disruption ofplasma lipoproteins.
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Sample processing and storage temperature, on the other hand, had line width
broadening effects on the measurements of the plasma lipoprotein methylene
resonance line width. When samples were processed at room temperature or were
allowed to stand at room temperature overnight before processing, a significant
increase in lactate doublet was observed at 1.35 ppm. The effect oflactate doublet on
line width measurement is clearly shown in Fig. 1. When samples were placed on ice
immediately after collections and processed at 4°C, the growth oflactate doublet was
minimized, most likely by slowing down red blood cell (RBC) glycolysis. Lactate
signal was still present to some degree, however, even when samples were processed
at optimal conditions, probably because normal plasma contains 0.5-2.2 mmol/liter
of lactic acid, and lactate levels can be elevated from hypoxia, hemorrhage, shock,
sepsis, cirrhosis, or exercise. Ingrowth of lactate in samples was minimized for at
least 20 days by storing samples at 4°C, and the average line width did not change
significantly. Furthermore, some precipitates were noted in all samples stored up to
20 days, but the line width measurements did not change. Others have reported,
however, that samples kept at 4°C for twoweeks had a marked increase in line width
measurement (three out offour samples) [16].
Although the prolonged storage ofplasma samples at 4°C had no significant effect
on the average line width ofplasma lipid resonances, the RI increased with storage
time and exhibited a difference after only three days. The large increase in methyl
peak intensity at short variable delay suggested that the precipitation or decomposi-
tion of a plasma component initially present in the broad resonances beneath the
methyl envelope may be responsible for the observed rise in RI as a function oftime.
While the mechanism responsible for these increasing RI values is not clear and
warrants further study, it could be related to the precipitates formed in samples after
prolonged storage.
The effect ofdietwas studied in one normal subject after a heavymeal. The proton
NMR acquisition and processing conditions were held constant so that the area of
the resonance envelopes could be used to reflect lipid concentrations accurately.
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Even though the lipid resonances were increased in intensity as expected, the
average line width decreased 3.6 Hz (10percent decrease). Mims et al. also reported
5 to 15 percent decrease in the average line width ofplasma samples taken from four
subjects aftereating [16]. Since themajor effect of a meal on plasma is an increase in
the total triglyceride level, it was plausible to assume that the decrease in average
line width may be related to the rise in triglyceride level. When the average line
widths ofseveral normal and cancerpatients were plotted against the total triglycer-
ide level, a significant inverse linear correlation was noted between line widths and
triglyceride concentrations.
A correlation between plasma triglyceride level and the average line width of
lipoprotein lipid resonances has been demonstrated by Wilding et al. [15] and Mims
et al. [16]. Wilding reported a logarithmic correlation of y = 110(X-027) with
coefficient of correlation of -.91, and Mims reported an inverse linear correlation
below triglyceride level of 120 mg/dl with r = -.643.
The mechanism ofthe inverse correlation between line width and triglyceride level
in plasma could be due to several factors. First we must consider that the methylene
and methyl proton NMR peaks of plasma lipoproteins are composite peaks of
various plasma lipoprotein species: chylomicrons, very-low-density lipoprotein
(VLDL), LDL, and HDL. In normal fasting plasma, lipid molar components are as
follows: phospholipids 35 percent, cholesterol esters 36 percent, triacylglycerols 13
percent, cholesterol 15 percent, and free fatty acids 6 percent [9]. Since it has been
reported that line width canvary in different lipid classes-the narrowest in VLDL,
the primary carrier of triglyceride, and broadest in LDL, the primary carrier of
cholesterol and phospholipids [171-it is logical to assume that plasma lipid with a
high triglyceride level will show narrower line width. Mountford et al. have shown
that ifplasmalipid NMRspectra are dominated by VLDL (triglyceride) peaks, then
the average line width is narrower [18].
Second, since the plasma lipoprotein species can exist in either crystalline or
liquid-like states [7], the proton resonance line widths will depend on the physical
state ofthelipid, with narrowpeaksarising from liquid components and broad peaks
arising fromcrystallinecomponents[17]. Line width oflipids in liquid-like states are
narrower because the mobility of methyl and methylene groups of the lipids is
increased. We have shown that when aplasma sample with low triglyceride level (42
mg/dl) is heated from 10 to40°C, lipid line width can decrease from 30 to 20 Hz (33
percent) with a transition temperature between 15-25°C. This observation is in
reasonable agreement with that of Deckelbaum et al., who reported the phase
transition temperature ofLDL to be28.3°C [4]. The second sample with a relatively
hightriglyceride level (129mg/dl) did not show any narrowing in lipid line width (17
to 16 Hz) because increasing triglyceride content lowers the transition temperature
in intact LDL,presumablythrough the effect oftriglyceride on the cholesterol esters
in LDL [18].
Third, the plasma lipid line width can also be influenced by intermolecular
interactions within the lipoproteins [1,6,16,18]. The long-chain aliphatic groups of
plasma lipids can interact through hydrophobic attractions, resulting in decreased
molecular mobility and flexibility. The reduced motion can result in broader line
widths and decreased values forT2.
Fossel et al. stated that the decreased intermolecular interactions via an unknown
mechanism in the plasma of patients with malignant tumors is the basis for the
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narrowing ofmethyl and methylene resonances in the proton NMR spectra [1]. They
proposed that host response to malignant tumors may affect the plasma lipid line
width either by eliciting structural differences in lipids or through the presence of
additional components in the lipoproteins. Soon after Fossel's publication, Mount-
ford et al. demonstrated the presence ofa distinct proteolipid (lipoprotein) complex
containing a 20 percent glycolipid component (fucogangliosides) in the plasma of a
patientwith ovarian cancer [5]. Even though the authorsclaimed that the fucogangli-
oside is responsible for the narrowing of the line width, others reported that the
concentration of the "oncolipid" is much smaller than that of VLDL and that it
would not be detectable by Fossel's method [14]. Furthermore, addition of a new
glycolipid resonance to the plasma lipoprotein lipid resonances envelope would not
be expected to decrease the line width but rather to increase the line width or to
leave it unchanged.
Our study and others have shown that the plasma triglyceride level has a profound
effect on the average plasmalipid linewidth measurement. Hypertriglyceridemia has
been observed in humans with cancer and in animals in response to tumors. Rouzer
and Cerami observed that serum ofrabbits infectedwith Trypanosoma bruceibecame
remarkably lipemic, with a major component being triglycerides [19]. Spiegel et al.
reported that patients with acute leukemia and non-Hodgkin's lymphoma have low
levels of HDL and elevated VLDL and triglycerides in their serum [20]. In both
cases, it was thought that the rise in triglyceride is probably due to an abnormality in
systemic triglyceride clearance metabolism. Later, aunique macrophage protein also
known as cachectin, which is responsible for suppression of lipoprotein lipase
activity, was isolated by Beutler et al. [21]. It is suggested that, in response to the
growth of cancer cells, activated macrophages release cachectin, a multipotent
cytokine which can cause tumor necrosis and cachexia.
It is possible that the effect of line width narrowing seen by Fossel et al. in cancer
patients could be due to the rise in triglyceride in serumbythe action ofcachectin on
lipoprotein lipase. It is then clear that the "Fossel test" is not a specific test in
screening cancer because any disease process which can cause a rise in serum
triglyceride level would give a false-positive result. One may, however, be able to
utilize this technique in following progression ofcancer, once it has been established
that a patient has malignancy. Even though one could achieve the same goal by
measuring serum triglyceride levels or lipoprotein lipase activity, NMR may be a
more sensitive, faster, and easier method of studying plasma lipoproteins. Even
though NMR is not very cost-effective at this time, it may be possible to reduce the
cost by tailoring a spectrometer specifically aimed at studying plasma lipoproteins.
Research is already in progressby Otvos et al. to study selectively plasma lipoprotein
components using NMR spectroscopy [personal communication].
Recently, Schuhmacher et al. have demonstrated that T2 measurements in combi-
nation with apolipoprotein-A level in plasma can discriminate tumor patients from
healthy controls with specificity and sensitivity of 96.5 percent and 80 percent [28].
Such measurements were shown to be a reflection ofgeneral inflammatory response
of the host to tumor, since T2 correlated inversely with plasma fibrinogen levels and
erythrocyte sedimentation rate. Other hematologic parameters as well as NMR T1
and T2 measurements failed to differentiate between malignant and non-malignant
disease processes, thus again arguing against the use of NMR T1 and T2 measure-
ments to screen for cancer. Nevertheless, the usefulness of NMR in following the
7576 LIM ET AL.
progression of malignant tumors or regression after a therapy may need further
investigation and mayprove tobe a useful tool in the management ofcancerpatients.
Arecent commentary on NMR spectroscopy in cancer patients concludes that the
weight of the evidence does not allow the use of this technique for diagnostic
purposes [29].
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